Yuan Gao
Southern Medical University
8 Papers
Yuan Gao is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Development and Validation of a 18F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of Malignancy
Hao-Yue Guo,Jun-Tao Lin,Hao-Hua Huang,Yuan Gao,Mei-Ru Yan,Ming Sun,Wei-Ping Xu,Hong-Hong Yan,Wen-Zhao Zhong,Xue-Ning Yang +9 more
TL;DR: A prediction model based on 18F-fludeoxyglucose positron emission tomography/computed tomography (PET/CT) for solid pulmonary nodules (SPNs) with highmalignant probability could permit accurate diagnoses and may be recommended to identify malignant SPNs with high malignant probability only.
16
Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.
Ying Wang,Lina Zhang,Jinjing Tan,Zhiyun Zhang,Yanxia Liu,Xingsheng Hu,Baohua Lu,Yuan Gao,Li Tong,Zan Liu,Hongxia Zhang,Peter Lin,Baolan Li,Olivier Gires,Hongmei Zhang +14 more
TL;DR: This study provides evidence for the first time that comprehensive analyses of CTCs, CTECs, and their respective CD44v6+ subtypes enable clinical stratification and improve prognostic prediction of SCLC, particularly for potentially curable LD-SCLC.
6
A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice
TL;DR: For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method as discussed by the authors .
3
Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer
Ying Wang,Yanxia Liu,Zhiyun Zhang,Baohua Lu,Yuan Gao,Li Tong,Mingming Hu,Peter Lin,Baolan Li,Hongmei Zhang +9 more
TL;DR: In this paper , the authors investigated the clinical utility of diverse aneuploid CTC subtypes and particularly CTC-associated white blood cell (CTC-WBC) clusters in predicting treatment response, prognosis and real-time monitoring disease progression in advanced driver gene-negative non-small lung cancer (NSCLC) patients.
Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas
TL;DR: Wang et al. as mentioned in this paper collected data from lung adenocarcinoma datasets of the Cancer Genome Atlas (TCGA-LUAD) and found the two differentially expressed ferroptosis subtypes can predict clinical outcomes and therapeutic responses in LUAD patients.